In Depth 11 Dec 2023 European patents in biotech: how to prevent invalid patents? …and development (R&D). Biotech firms rely heavily on patents for several reasons. Firstly, these patents safeguard the immense investment poured into research, as biotech companies dedicate a significant portion of… December 11, 2023 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 Dec 2017 Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017 …run-through of the best news coming out of the biotech industry in 2017. Novartis Wins the Race for CAR-T Approval 2017 saw a major biotech milestone surpassed with the FDA… December 18, 2017 - 9 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Best in Biotech 20 Feb 2024 Biotechs in the US Capital: seven key players based in Washington DC …the area of Washington D.C. is smaller than Virginia and Maryland where companies are spread across, Washington is still a destination of choice with innovative biotech companies and events. The… February 20, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Interview 14 Dec 2022 Sibylla Biotech: how physicists met biologists to discover new drugs Discovering new drugs remains an inefficient, trial and error-based process. The founding team behind the Italian startup Sibylla Biotech explain how their interdisciplinary approach can speed up drug discovery in… December 14, 2022 - 9 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 19 Mar 2018 How is Biotech Putting a Spring into the Step of Sportsmen and Women Around the World? Biotech has helped the likes of Cristiano Ronaldo and Rafael Nadal to return to fitness after injury. What else could this technology do to help athletes around the world excel?… March 19, 2018 - 6 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Interview 17 Apr 2019 What Does the Future Hold for European Biotech? Insights from Evotec’s CEO As the CEO of Evotec, one of Europe’s largest biotech companies, Werner Lanthaler is in a unique position to look into the future of the biotech industry. At Labiotech Refresh… April 17, 2019 - 7 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 8 Oct 2024 Top biotech deals of September 2024 …there were other noteworthy pacts made. American biotech Genentech – run by multinational Roche Holding – grabbed Chinese-American biotech Regor Pharmaceuticals’ CDK inhibitors to target breast cancer. Genentech is paying… October 8, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 2 Jun 2025 Top biotech deals in May 2025 …$0.57 in cash per share of Kronos’ common stock. Biotech deals by approach in May 2025 Biotechs want in on RNA interference City Therapeutics is a biotech in Massachusetts that… June 2, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 6 Feb 2023 The biggest private biotech investments in January 2023 …the biggest funding rounds. 2023 began with a bang in terms of biotech funding, and there are signs of stabilization in biotech stocks after two difficult years. We’ve gathered the… February 6, 2023 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 5 Dec 2024 The biggest private biotech investments in November 2024 …biggest funding rounds overall. Table of contents Biggest biotech investments by value in November 2024 The biggest private biotech funding round of November 2024 went to Metsera, which raised $215… December 5, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Interview 25 Apr 2018 Planting the Seeds to Grow the Italian Biotech Industry …commercial activity, either by collaborating with pharmaceutical and biotech companies, or by creating their own biotechs.” For those skeptic that Italy can really make it to Europe’s first league, Seghezzi… April 25, 2018 - 3 minutesmins - By Editorial Team Share WhatsApp Twitter Linkedin Email
In Depth 30 May 2022 Decentralized autonomous organizations are changing how biotechs are run …which kinds of problems the industry tackles. Decentralized biotechs are different from traditional biotechs because they are less reliant on a single, central lab facility and supply chain. Decentralized biotech… May 30, 2022 - 8 minutesmins - By Sachin Rawat Share WhatsApp Twitter Linkedin Email